These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19324321)

  • 1. Right ventricular cardiomyopathy in the young: an emerging challenge.
    Hamilton RM; Fidler L
    Heart Rhythm; 2009 Apr; 6(4):571-5. PubMed ID: 19324321
    [No Abstract]   [Full Text] [Related]  

  • 2. The research venture in arrhythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine.
    Thiene G
    Eur Heart J; 2015 Apr; 36(14):837-46. PubMed ID: 25636746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arrhythmogenic right ventricular cardiomyopathy].
    Benn M; Hansen PS; Lund B; Schiønning JD; Baandrup U; Pedersen AK
    Ugeskr Laeger; 1998 Mar; 160(10):1454-9. PubMed ID: 9520612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arrhythmogenic right ventricular cardiomyopathy and sudden cardiac death in young Koreans.
    Kasikcioglu E
    Circ J; 2004 Apr; 68(4):401; author reply 401-2. PubMed ID: 15080166
    [No Abstract]   [Full Text] [Related]  

  • 5. Arrhythmogenic right ventricular cardiomyopathy.
    Pike R
    Can J Cardiovasc Nurs; 2009; 19(2):5-9. PubMed ID: 19517899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arrhythmogenic right ventricular cardiomyopathy/dysplasia as a cause of sudden cardiac death].
    Gordeeva MV; Mitrofanova LB; Grokhotova VV
    Arkh Patol; 2013; 75(6):51-5. PubMed ID: 24624846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrhythmogenic Right Ventricular Cardiomyopathy.
    Corrado D; Link MS; Calkins H
    N Engl J Med; 2017 Jan; 376(1):61-72. PubMed ID: 28052233
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic management in Sicilian patients with definite arrhythmogenic right ventricular dysplasia/cardiomyopathy and focus on the role of implantable cardioverter-defibrillator therapy.
    Inciardi RM; Rotolo A; Coppola G; Clemenza F; Giordano U; Lombardo E; Schicchi R; Torcivia R; Arrotti S; Leggio G; Novo S; Assennato P
    Int J Cardiol; 2014 Apr; 172(3):e468-9. PubMed ID: 24485618
    [No Abstract]   [Full Text] [Related]  

  • 9. Arrhythmogenic right ventricular dysplasia: from genetics to treatment.
    Khan A; Mittal S; Sherrid MV
    Anadolu Kardiyol Derg; 2009 Dec; 9 Suppl 2():24-31. PubMed ID: 20089484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Clinical Outcome of Arrhythmogenic Right Ventricular Cardiomyopathy in Individuals With a p.S358L Mutation in TMEM43 Following Implantable Cardioverter Defibrillator Therapy.
    Hodgkinson KA; Howes AJ; Boland P; Shen XS; Stuckless S; Young TL; Curtis F; Collier A; Parfrey PS; Connors SP
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):. PubMed ID: 26966288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing Sudden Death in Arrhythmogenic Cardiomyopathy: Careful Family and Genetic Evaluation Key to Appropriate Diagnosis and Management.
    Ortiz-Genga M; García-Hernández S; Monserrat-Iglesias L; McKenna WJ
    Can J Cardiol; 2021 Jun; 37(6):819-821. PubMed ID: 33359000
    [No Abstract]   [Full Text] [Related]  

  • 12. Arrythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) and cathecholaminergic polymorphic ventricular tachycardia (CPVT): A phenotypic spectrum seen in same patient.
    Patel H; Shah P; Rampal U; Shamoon F; Tiyyagura S
    J Electrocardiol; 2015; 48(5):874-8. PubMed ID: 26082335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arrhythmogenic Right Ventricular Cardiomyopathy: Overview and Case Study.
    Tennyson CD; Yapejian R
    AACN Adv Crit Care; 2022 Mar; 33(1):14-22. PubMed ID: 35259221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arrhythmogenic right ventricular cardiomyopathy 2012: diagnostic challenges and treatment.
    Marcus FI; Abidov A
    J Cardiovasc Electrophysiol; 2012 Oct; 23(10):1149-53. PubMed ID: 22909229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: a role for genotyping in decision-making?
    Wichter T; Breithardt G
    J Am Coll Cardiol; 2005 Feb; 45(3):409-11. PubMed ID: 15680720
    [No Abstract]   [Full Text] [Related]  

  • 16. Arrhythmogenic forms of heart failure in children.
    Berger S; Dubin AM
    Heart Fail Clin; 2010 Oct; 6(4):471-81, viii. PubMed ID: 20869647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic analysis of arrhythmogenic cardiomyopathy in the Hutterite population: role of electrocardiogram in identifying high-risk desmocollin-2 carriers.
    Wong JA; Duff HJ; Yuen T; Kolman L; Exner DV; Weeks SG; Gerull B
    J Am Heart Assoc; 2014 Dec; 3(6):e001407. PubMed ID: 25497880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification for sudden death in arrhythmogenic right ventricular cardiomyopathy.
    Cadrin-Tourigny J; Tadros R; Talajic M; Rivard L; Abadir S; Khairy P
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):653-64. PubMed ID: 25947965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic right ventricular dysplasia.
    Calkins H
    Curr Probl Cardiol; 2013 Mar; 38(3):103-23. PubMed ID: 23453020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and therapy of arrhythmogenic right ventricular cardiomyopathy].
    Zorzi A; Rigato I; Migliore F; Perazzolo Marra M; Basso C; Thiene G; Bauce B; Corrado D
    G Ital Cardiol (Rome); 2014 Nov; 15(11):616-25. PubMed ID: 25424140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.